伐地那非增加EGCG-β-乳球蛋白纳米粒对肝癌细胞的抑制作用

doi:10.13305/j.cnki.jts.2020.04.009

茶叶科学 ›› 2020, Vol. 40 ›› Issue (4): 528-535.doi: 10.13305/j.cnki.jts.2020.04.009

伐地那非增加EGCG-β-乳球蛋白纳米粒对肝癌细胞的抑制作用

陈春晓, 楼文雨, 丁镇建, 李卓烨, 杨媛媛, 金鹏, 杜琪珍^*

浙江农林大学农业与食品科学学院,浙江杭州 311300

收稿日期:2019-10-09 修回日期:2020-04-11 出版日期:2020-08-15 发布日期:2020-08-18
通讯作者: *qizhendu@163.com
作者简介:陈春晓，女，硕士研究生，主要从事天然活性物质方面的研究。
基金资助:
浙江省重点研发（2019C02072）、浙江农林大学大学生创新（113-2013200135、115-2013200021）

Vardenafil Improves the Proliferative Inhibition of EGCG-β-lactoglobulin Nanoparticles Against Liver Cancer Cells

CHEN Chunxiao, LOU Wenyu, DING Zhenjian, LI Zhuoye, YANG Yuanyuan, JIN Peng, DU Qizhen^*

School of Agricultural and Food Science, Zhejiang Agriculture and Forestry University, Hangzhou 311300, China

Received:2019-10-09 Revised:2020-04-11 Online:2020-08-15 Published:2020-08-18

摘要/Abstract

摘要： 较高浓度的EGCG才能抑制癌细胞的增殖,通过纳米化和EGCG与其他药物的联合使用是提高EGCG生物活性的重要策略。本研究将EGCG和伐地那非（VD）同时包埋于β-乳球蛋白（β-Lg）纳米载体中,制备出EGCG-VD-β-Lg纳米粒（EVβ-NPs）,体外试验证实,EVβ-NPs能提高人肝癌细胞（HepG2细胞）中Caspase-3活性,使HepG2细胞在S期产生明显的阻滞,诱发细胞核分裂,从而导致HepG2细胞凋亡。研究结果表明,将EGCG与微量的VD联合使用,并通过纳米化包埋可以显著提高EGCG的抗癌活性。这一方法在EGCG抗癌制品的开发方面具有潜在的价值。

关键词: 表没食子儿茶素没食子酸酯, 伐地那非, β-乳球蛋白;, 纳米粒, 增殖抑制

Abstract: The combination of nano and other drugs is an important strategy to improve the biological activity of EGCG, since a high EGCG concentration is essential for the inhibition of the proliferation of cancer cells. In this study, EGCG-vardenafil (VD)-β-lactoglobulin (β-Lg)-nanoparticles (EVβ-NPs) was prepared by encapsulating EGCG and VD in β-Lg nano-carriers. In vitro experimental results show that EVβ-NPs could upgrade the activity of caspase-3 in HepG2 cells compared to the native EGCG, which caused cell cycle arrest in the S phase of HepG2 cells to induce cell nuclear division, and finally lead to HepG2 cell apoptosis. The results demonstrate that the encapsulation of EGCG-VD can significantly improve the anticancer activity of EGCG, and possesses potential value in the development of EGCG anticancer products.

Key words: EGCG, vardenafil, β-lactoglobulin, nanoparticles, proliferative inhibition

中图分类号:

陈春晓, 楼文雨, 丁镇建, 李卓烨, 杨媛媛, 金鹏, 杜琪珍. 伐地那非增加EGCG-β-乳球蛋白纳米粒对肝癌细胞的抑制作用[J]. 茶叶科学, 2020, 40(4): 528-535. doi: 10.13305/j.cnki.jts.2020.04.009.

CHEN Chunxiao, LOU Wenyu, DING Zhenjian, LI Zhuoye, YANG Yuanyuan, JIN Peng, DU Qizhen. Vardenafil Improves the Proliferative Inhibition of EGCG-β-lactoglobulin Nanoparticles Against Liver Cancer Cells[J]. Journal of Tea Science, 2020, 40(4): 528-535. doi: 10.13305/j.cnki.jts.2020.04.009.

参考文献 21

[1]	刘超, 陈若芸. 儿茶素及其类似物的化学和生物活性研究进展[J]. 中国中药杂志, 2004, 29(10): 1017-1021.Liu C, Chen R Y.Advance of chemistry and bioactivities of catechin and its analogues[J]. China Journal of Chinese Materia Medica, 2004, 29(10): 1017-1021.
[2]	Ponniah K, Loo T S, Edwards P J, et al.The production of soluble and correctly folded recombinant bovine β-lactoglobulin variants A and B in Escherichia coli for NMR studies[J]. Protein Expr Purifi, 2010, 70(2): 283-289.
[3]	Liang L, Tajmir-Riahi H A, Subirade M. Interaction of β-lactoglobulin with resveratrol and its biological implications[J]. Biomacromolecules, 2008, 9: 50-56.
[4]	Sneharani A H, Karakkat J V, Singly S A.Interaction of curcumin with β-lactoglobulin stability, spectroscopic analysis, and molecular modeling of the complex[J]. Journal of Agricultural and Food Chemistry, 2010, 58: 11130-11139.
[5]	Zimet P, Livney Y D.Beta-lactoglobulin and its nanocomplexes with pectin as vehicles for ω-3 polyunsaturated fatty acids[J]. Food Hydrocoll, 2009, 23: 1120-1126.
[6]	Kumazoe M, Sugihara K, Tsukamoto S, et al.67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis[J]. J Clin Invest, 2013, 123(2): 787-99.
[7]	黄美蓉, 应浩, 江用文, 等. EGCG纳米粒的制备及其抗肿瘤活性研究[J]. 茶叶科学, 2015, 35(6): 605-612.Huang M R, Ying H, Jiang Y W, et al.Research on preparation and antitumor activity of EGCG naonparticles[J]. Journal of Tea Science, 2015, 35(6): 605-612.
[8]	Shpigelman A, Israeli G, Livney Y D.Thermally-induced protein-polyphenol co-assemblies: beta lactoglobulin-based nanocomplexes as protective nanovehicles for EGCG[J]. Food Hydrocoll, 2010, 24(8): 735-743.
[9]	Li B, Du W, Jin J, et al.Preservation of (-)-epigallocatechin-3-gallate antioxidant properties loaded in heat treated β-lactoglobulin nanoparticles[J]. J Agriculture Food Chemistry, 2012, 60: 3477-3484.
[10]	成惠林. 检测细胞活性的MTT方法[J]. 江苏医药, 1996, 22(5): 330-331.Cheng H L.MTT method for the detection of cell activity[J]. Jinagsu Med J, 1996, 22(5): 330-331.
[11]	周建军, 乐秀芳, 韩家娴, 等. 影响MTT方法测定结果的一些因素[J]. 肿瘤, 1994, 14(2): 93-94.Zhou J J, Le X F, Han J X, et al.The factors influencing the results of MTT[J]. Tumor, 1994, 14(2): 93-94.
[12]	Mu?ller R H, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future[J]. Adv Drug Delivery Rev, 2001(47): 3-19.
[13]	Timasheff S N, Townend R.Molecular interactions in β-lactoglobulin. I. The association of the genetic species of β-lactoglobulin below the isoelectric point[J]. J Am Chem Soc, 1961, 83(2): 464-469.
[14]	Chithrani B D, Ghazani A A, Chan W C W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells[J]. Nano Lett, 2006, 6: 662-668.
[15]	Yang C S, Wang X, Lu G, et al.Cancer prevention by tea: animal studies, molecular mechanisms and human relevance[J]. Nat Rev Cancer 2009, 9: 429-439.
[16]	Wu M, Jin J, Jin P, et al.Epigallocatechin gallate-β-lactoglobulin nanoparticles improve the antitumor activity of EGCG for inducing cancer cell apoptosis[J]. J Funct Food, 2017, 39: 257-263.
[17]	Fan Y, Zhang Y, Yokoyama W, et al.β-Lactoglobulin-chlorogenic acid conjugate-based nanoparticles for delivery of (-)-epigallocatechin-3-gallate[J]. RSC Adv, 2017, 7(35): 21366-21374.
[18]	Yang Y, Jin P, Zhang X, et al.New epigallocatechin gallate (EGCG) nanocomplexes co-assembled with 3-mercapto-1-Hexanol and β-lactoglobulin for improvement of antitumor activity[J]. J Biomedi Nanotechnol, 2017, 13(7): 805-814.
[19]	Zhang L, Sahu I D, Xu M, et al.Effect of metal ions on the binding reaction of (-)-epigallocatechin gallate to β-lactoglobulin[J]. Food Chemistry, 2017, 221: 1923-1929.
[20]	Corbin J D, Beasley A, Blount M A, et al.Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP specific phosphodiesterase-5 (PDE5)[J]. Neurochem Int, 2004, 45: 859-863.
[21]	Li Q, Shu Y.Pharmacological modulation of cytotoxicity and cellular uptake of anti-cancer drugs by PDE5 Inhibitors in lung cancer cells[J]. Pharma Res, 2014, 31: 86-96.

伐地那非增加EGCG-β-乳球蛋白纳米粒对肝癌细胞的抑制作用

Vardenafil Improves the Proliferative Inhibition of EGCG-β-lactoglobulin Nanoparticles Against Liver Cancer Cells

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 21

相关文章 13

Metrics

本文评价

推荐阅读 0

[1]	罗璐璐, 赵悦汐, 王彦博, 幸怡, 齐洋, 马宏炜, 程林峰, 张芳琳. 表没食子儿茶素没食子酸酯抗汉滩病毒效果研究[J]. 茶叶科学, 2025, 45(1): 145-156.
[2]	杨楠, 李转, 刘玫辰, 马骏杰, 石云桃, 魏湘凝, 林阳顺, 毛宇源, 高水练. 钾营养对茶树EGCG生物合成的调控作用研究[J]. 茶叶科学, 2024, 44(6): 887-900.
[3]	丁树洽, 谢昕雅, 刘助生, 廖贤军, 刘仲华, 蔡淑娴. 茶叶成分EGCG与L-theanine联合应用的神经保护作用研究[J]. 茶叶科学, 2024, 44(5): 779-792.
[4]	陈佳欣, 张锦佳, 左会灵, 焦宇航, 石安华. 表没食子儿茶素没食子酸酯预防并改善非酒精性脂肪性肝病的作用机制及研究进展[J]. 茶叶科学, 2024, 44(4): 543-553.
[5]	徐燕, 蔡吓强, 解千金, 邰玲玲, 刘增辉. 表没食子儿茶素没食子酸酯和维生素C联用对高尿酸血症小鼠血尿酸水平的影响[J]. 茶叶科学, 2020, 40(3): 407-414.
[6]	方洪枫, 张慧霞, 王国红, 杨民和. 混菌发酵绿茶产脂肪酶及其对酯型儿茶素的水解作用分析[J]. 茶叶科学, 2019, 39(1): 88-97.
[7]	祁洁, 徐颖磊, 梁文怡, 费朵, 乌昕儿, 金建昌, 杜琪珍, 许勇泉, 高颖. EGCG纳米载体制备技术及其对EGCG活性影响的研究进展[J]. 茶叶科学, 2017, 37(2): 119-129.
[8]	刘洪国. EGCG对肾缺血再灌注损伤的保护作用及其作用机制的研究[J]. 茶叶科学, 2016, 36(2): 169-174.
[9]	黄美蓉, 应浩, 江用文, 江和源, 杜琪珍. EGCG纳米粒的制备及其抗肿瘤活性研究[J]. 茶叶科学, 2015, 35(6): 605-612.
[10]	严煜钧, 刘仲华, 林勇, 黄建安, 彭彬, 蒋华军. 茶叶中EGCG对非酒精性脂肪肝大鼠的调脂保肝作用研究[J]. 茶叶科学, 2014, 34(3): 221-229.
[11]	伍妍俊, 汪小钢, 宛晓春. 甲基化EGCG的研究现状及展望[J]. 茶叶科学, 2010, 30(6): 407-413.
[12]	沈生荣, 杨贤强, 赵保路, 忻文娟. 茶多酚体外助氧化作用的自由基机理[J]. 茶叶科学, 1992, 12(02): 145-150.
[13]	沈生荣, 杨贤强, 赵保路, 忻文娟. 茶多酚复合体及(一)——EGCG对氧自由基的清除作用[J]. 茶叶科学, 1992, 12(01): 59-64.